Breyanzi
Active substance: lisocabtagene maraleucel
lisocabtagene maraleucel
Centralised EU authorisationActive
Marketing holder: Bristol-Myers Squibb Pharma EEIG
Verified 2026-10-09 · EMA
- Source: EMA
Composition
- lisocabtagene maraleucel
Registration
- Registration number
- EMEA/H/C/004731
- Registration status
- Active
- ATC code
- L01XL08
Sources
- product · EMA · EMEA/H/C/004731 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004731 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004731 · Verified 2026-10-09